Názov: | Enalaprilat increases PPAR beta/delta expression, without influence on PPAR alpha and PPAR gamma, and modulate cardiac function in sub-acute model of daunorubicin-induced cardiomyopathy. | |
Zápis: |
ČERNECKÁ, Hana - OCHODNICKÁ-MACKOVIČOVÁ, Katarína - KUČEROVÁ, Dana - KMECOVÁ, Jana - NEMČEKOVÁ, Viera - DOKA, Gabriel - KYSELOVIČ, Ján - KŘENEK, Peter - OCHODNICKÝ, Peter - KLIMAS, Ján. Enalaprilat increases PPAR beta/delta expression, without influence on PPAR alpha and PPAR gamma, and modulate cardiac function in sub-acute model of daunorubicin-induced cardiomyopathy. In: European Journal of Pharmacology. 2013. ISSN 0014-2999, Vol. 714, no. 1-3 (2013), p. 472-477. (2013: 2.684 - IF, 174 - H-index, 2.754 - IF 5y, 0.907 - SJR, Q2 - SJR Best Q, Q2 - JCR Best Q) |
|
Rok vydania: | 2013 | |
Kategória: | ADC - Vedecké práce v zahraničných karentovaných časopisoch | |
Autori: | ČERNECKÁ Hana | 0 % |
OCHODNICKÁ-MACKOVIČOVÁ Katarína | 0 % | |
KUČEROVÁ Dana | 0 % | |
KMECOVÁ Jana | 0 % | |
NEMČEKOVÁ Viera | 0 % | |
DOKA Gabriel | 0 % | |
KYSELOVIČ Ján | 0 % | |
KŘENEK Peter | 0 % | |
OCHODNICKÝ Peter | 0 % | |
KLIMAS Ján | 0 % | |
Vydanie: | European Journal of Pharmacology Vol. 714, no. 1-3 (2013), p. 472-477 |
|
Krajina vydania: | Holandsko | |
ISSN: | 0014-2999 | |
Oblasť výskumu: | 180 - Lekárske, farmaceutické a nelekárske zdravotnícke vedy | |
Scientometria: | 2013: 2.684 - IF, 174 - H-index, 2.754 - IF 5y, 0.907 - SJR, Q2 - SJR Best Q, Q2 - JCR Best Q | |
Jazyk: | anglický |
Ohlasy: | |
---|---|
2021: [1] PANG, Shuo - DONG, Wei - LIU, Ning - GAO, Shan - LI, Jing - ZHANG, Xu - LU, Dan - ZHANG, Lianfeng. Diallyl sulfide protects against dilated cardiomyopathy via inhibition of oxidative stress and apoptosis in mice. In MOLECULAR MEDICINE REPORTS. ISSN 1791-2997, 2021, vol. 24, no. 6, pp. Dostupné na: https://doi.org/10.3892/mmr.2021.12492. [WoS] | |
2021: [1] VEEDER, Justin A. - HOTHEM, Lauren N. - CIPRIANI, Amber E. - JENSEN, Brian C. - RODGERS, Jo E. Chemotherapy-associated cardiomyopathy: Mechanisms of toxicity and cardioprotective strategies. In PHARMACOTHERAPY. ISSN 0277-0008, 2021, vol. 41, no. 12, pp. 1066-1080. Dostupné na: https://doi.org/10.1002/phar.2638. [WoS] |